PortfoliosLab logoPortfoliosLab logo
PHGE vs. ARCC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PHGE vs. ARCC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BiomX Inc. (PHGE) and Ares Capital Corporation (ARCC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PHGE achieves a -53.57% return, which is significantly lower than ARCC's -5.14% return.


PHGE

1D
-0.82%
1M
15.76%
YTD
-53.57%
6M
-80.75%
1Y
-90.88%
3Y*
-77.02%
5Y*
-76.28%
10Y*

ARCC

1D
-1.53%
1M
-2.61%
YTD
-5.14%
6M
-5.66%
1Y
-6.58%
3Y*
9.07%
5Y*
8.64%
10Y*
12.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PHGE vs. ARCC - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
PHGE
BiomX Inc.
-53.57%-86.52%-73.93%49.97%-88.33%-74.92%-34.12%0.36%
ARCC
Ares Capital Corporation
-5.14%1.07%19.78%20.03%-3.84%36.14%0.86%17.43%

Correlation

The correlation between PHGE and ARCC is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Mar 14, 2019

0.11

Fundamentals

Market Cap

PHGE:

$2.26B

ARCC:

$13.41B

EPS

PHGE:

-$0.01

ARCC:

$1.63

Total Revenue (TTM)

PHGE:

$0.00

ARCC:

$2.63B

Gross Profit (TTM)

PHGE:

-$2.69M

ARCC:

$1.86B

EBITDA (TTM)

PHGE:

-$25.59M

ARCC:

$2.05B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PHGE vs. ARCC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PHGE
PHGE Risk / Return Rank: 1414
Overall Rank
PHGE Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
PHGE Sortino Ratio Rank: 1919
Sortino Ratio Rank
PHGE Omega Ratio Rank: 2020
Omega Ratio Rank
PHGE Calmar Ratio Rank: 44
Calmar Ratio Rank
PHGE Martin Ratio Rank: 44
Martin Ratio Rank

ARCC
ARCC Risk / Return Rank: 2525
Overall Rank
ARCC Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
ARCC Sortino Ratio Rank: 2121
Sortino Ratio Rank
ARCC Omega Ratio Rank: 2222
Omega Ratio Rank
ARCC Calmar Ratio Rank: 2929
Calmar Ratio Rank
ARCC Martin Ratio Rank: 2929
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PHGE vs. ARCC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BiomX Inc. (PHGE) and Ares Capital Corporation (ARCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PHGEARCCDifference
Sharpe ratioReturn per unit of total volatility

-0.08

Sortino ratioReturn per unit of downside risk

-0.13

Omega ratioGain probability vs. loss probability

0.94

0.95

-0.01

Calmar ratioReturn relative to maximum drawdown

-0.94

-0.34

-0.60

Martin ratioReturn relative to average drawdown

-1.61

-0.63

-0.98

PHGE vs. ARCC - Sharpe Ratio Comparison

The current PHGE Sharpe Ratio is -0.44, which is comparable to the ARCC Sharpe Ratio of -0.36. The chart below compares the historical Sharpe Ratios of PHGE and ARCC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PHGEARCCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.44

-0.36

-0.08

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.48

0.43

-0.91

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.49

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.47

0.37

-0.84

Drawdowns

PHGE vs. ARCC - Drawdown Comparison

The maximum PHGE drawdown since its inception was -99.98%, which is greater than ARCC's maximum drawdown of -79.36%. Use the drawdown chart below to compare losses from any high point for PHGE and ARCC.


Loading charts...

Drawdown Indicators


PHGEARCCDifference

Max Drawdown

Largest peak-to-trough decline

-99.98%

-79.36%

-20.62%

Max Drawdown (1Y)

Largest decline over 1 year

-96.97%

-19.35%

-77.62%

Max Drawdown (3Y)

Largest decline over 3 years

-99.71%

-19.35%

-80.36%

Max Drawdown (5Y)

Largest decline over 5 years

-99.97%

-21.76%

-78.21%

Max Drawdown (10Y)

Largest decline over 10 years

-56.77%

Current Drawdown

Current decline from peak

-99.96%

-13.66%

-86.30%

Average Drawdown

Average peak-to-trough decline

-72.80%

-9.10%

-63.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

56.45%

10.48%

+45.97%

Volatility

PHGE vs. ARCC - Volatility Comparison

BiomX Inc. (PHGE) has a higher volatility of 100.27% compared to Ares Capital Corporation (ARCC) at 3.94%. This indicates that PHGE's price experiences larger fluctuations and is considered to be riskier than ARCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PHGEARCCDifference

Volatility (1M)

Calculated over the trailing 1-month period

100.27%

3.94%

+96.33%

Volatility (6M)

Calculated over the trailing 6-month period

168.21%

14.71%

+153.50%

Volatility (1Y)

Calculated over the trailing 1-year period

207.12%

18.40%

+188.72%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

160.82%

19.96%

+140.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

139.27%

25.58%

+113.69%

Dividends

PHGE vs. ARCC - Dividend Comparison

PHGE has not paid dividends to shareholders, while ARCC's dividend yield for the trailing twelve months is around 10.28%.


PositionTTM20252024202320222021202020192018201720162015
ARCC
Ares Capital Corporation
10.28%9.49%8.77%9.59%10.12%7.65%9.47%9.01%9.88%9.67%9.22%11.02%
PHGE
BiomX Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PHGE vs. ARCC - Financials Comparison

This section allows you to compare key financial metrics between BiomX Inc. and Ares Capital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M202220232024202520260
763.00M
(PHGE) Total Revenue
(ARCC) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PHGE and ARCC have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PHGE has higher volatility (100.27%) compared to ARCC (3.94%). In terms of maximum drawdown, PHGE dropped -99.98% vs ARCC's -79.36%.

ARCC currently has the higher Sharpe Ratio (-0.36 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PHGE and ARCC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer